Amedeo Smart

Free Medical Literature Service



Hepatitis C

  Free Subscription

Articles published in
    August 2021
  1. CHIDAMBARAM V, Jones JM, Lokhandwala PM, Bloch EM, et al
    Low rates of transfusion-transmitted infection screening in chronically transfused adults with sickle cell disease.
    Transfusion. 2021;61:2421-2429.
    >> Share

    January 2021
  2. STEELE WR, Dodd RY, Notari EP, Haynes J, et al
    HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12-month deferral policy for men who have sex with men.
    Transfusion. 2021 Jan 18. doi: 10.1111/trf.16250.
    >> Share

    October 2020
  3. COLEMAN C, Lelie N, Rademeyer R, van Drimmelen H, et al
    Comparison of two nucleic acid amplification technology systems for detection of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus.
    Transfusion. 2020 Oct 16. doi: 10.1111/trf.16137.
    >> Share

    September 2020
  4. AN T, Dean M, Flower R, Tatzenko T, et al
    Understanding occult hepatitis C infection.
    Transfusion. 2020;60:2144-2152.
    >> Share

    August 2020
  5. STEELE WR, Dodd RY, Notari EP, Xu M, et al
    Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS).
    Transfusion. 2020 Aug 31. doi: 10.1111/trf.16005.
    >> Share

    June 2020
  6. BLOCH EM, Kipiani E, Shadaker S, Alkhazashvili M, et al
    Blood transfusion safety in the country of Georgia: collateral benefit from a national hepatitis C elimination program.
    Transfusion. 2020;60:1243-1252.
    >> Share

    February 2020
  7. DENG X, Zang L, Wang X, Chen H, et al
    Follow-up program for blood donors with unconfirmed screening results reveals a high false-positive rate in Dalian, China.
    Transfusion. 2020;60:334-342.
    >> Share

  8. BLATYTA PF, Kelly S, Sabino E, Preiss L, et al
    Prevalence of serologic markers of transfusion and sexually transmitted infections and their correlation with clinical features in a large cohort of Brazilian patients with sickle cell disease.
    Transfusion. 2020;60:343-350.
    >> Share

    November 2019
  9. CANDOTTI D, Sauvage V, Cappy P, Boullahi MA, et al
    High rate of hepatitis C virus and human immunodeficiency virus false-positive results in serologic screening in sub-Saharan Africa: adverse impact on the blood supply.
    Transfusion. 2019 Nov 27. doi: 10.1111/trf.15593.
    >> Share

    July 2019
  10. FU P, Lv Y, Zhang H, Liu C, et al
    Hepatitis C virus prevalence and incidence estimates among Chinese blood donors.
    Transfusion. 2019 Jul 4. doi: 10.1111/trf.15432.
    >> Share

    October 2018
  11. UCHIDA S, Satake M, Kurisu A, Sugiyama A, et al
    Incidence rates of hepatitis C virus infection among blood donors in Japan: a nationwide retrospective cohort study.
    Transfusion. 2018 Oct 30. doi: 10.1111/trf.14951.
    >> Share

    August 2018
  12. SEHEULT JN, Triulzi DJ, Kaplan A
    Targeted prospective hepatitis C virus "lookback" program: is it an efficient and effective use of resources?
    Transfusion. 2018;58:2084-2085.
    >> Share

    April 2018
  13. BUTLER EK, McCullough J
    Pathogen reduction combined with rapid diagnostic tests to reduce the risk of transfusion-transmitted infections in Uganda.
    Transfusion. 2018;58:854-861.
    >> Share

    February 2018
  14. SHAN Z, Huang J, Liao Q, Huang K, et al
    Association of killer cell immunoglobulin-like receptors with spontaneous clearance of hepatitis C virus in the Chinese population.
    Transfusion. 2018 Feb 15. doi: 10.1111/trf.14527.
    >> Share

  15. VAN REMOORTEL H, Borra V, De Buck E, Compernolle V, et al
    Is an endoscopic examination associated with transfusion-transmissible infections? A systematic review and meta-analysis.
    Transfusion. 2018;58:507-519.
    >> Share

    January 2018
  16. ROCHA D, Andrade E, Godoy DT, Fontana-Maurell M, et al
    The Brazilian experience of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in blood donors.
    Transfusion. 2018 Jan 30. doi: 10.1111/trf.14478.
    >> Share

    December 2017
  17. GALEL SA, Simon TL, Williamson PC, AuBuchon JP, et al
    Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations.
    Transfusion. 2017 Dec 17. doi: 10.1111/trf.14457.
    >> Share

    August 2017
  18. GAO Z, Zhang Y, Shan H, Shi L, et al
    A 30-year systematic review and meta-analysis of hepatitis B virus among blood donors in mainland China: revealing increase of new threats.
    Transfusion. 2017;57:1988-1997.
    >> Share

    July 2017
  19. TWAGIRUMUGABE T, Swaibu G, Bergstrom T, Walker TD, et al
    Low prevalence of hepatitis C virus RNA in blood donors with anti-hepatitis C virus reactivity in Rwanda.
    Transfusion. 2017 Jul 3. doi: 10.1111/trf.14204.
    >> Share

    June 2017
  20. VIEIRA PCM, Lamarao LM, Amaral CEM, Correa ASM, et al
    Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil.
    Transfusion. 2017 Jun 7. doi: 10.1111/trf.14146.
    >> Share

    May 2017
  21. CZERWINSKI M, Grabarczyk P, Stepien M, Kubicka-Russel D, et al
    What weighs more-low compliance with self-deferral or minor medical procedures? Explaining the high rate of hepatitis C virus window-period donations in Poland.
    Transfusion. 2017 May 28. doi: 10.1111/trf.14163.
    >> Share

    April 2017
  22. BISWAS A, Firdaus R, Gupta D, Ghosh M, et al
    Interferon lambda3 gene (IL28B) is associated with spontaneous or treatment-induced viral clearance in hepatitis C virus-infected multitransfused patients with thalassemia.
    Transfusion. 2017 Apr 16. doi: 10.1111/trf.14070.
    >> Share

    March 2017
  23. BLANCO S, Balangero MC, Valle MC, Montini OL, et al
    Usefulness of nucleic acid testing to reduce risk of hepatitis B virus transfusion-transmitted infection in Argentina: high rate of recent infections.
    Transfusion. 2017;57.
    >> Share

    February 2017
  24. GUO Z, Fu P, Yin Y, Wang F, et al
    The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitis C
    Transfusion. 2017 Feb 5. doi: 10.1111/trf.14014.
    >> Share

    January 2017
  25. VENDRAMIN C, McGuckin S, Alwan F, Westwood JP, et al
    A single-center prospective study on the safety of plasma exchange procedures using a double-viral-inactivated and prion-reduced solvent/detergent fresh-frozen plasma as the replacement fluid in the treatment of thrombotic microangiopathy.
    Transfusion. 2017;57:131-136.
    >> Share

  26. GALLIAN P, Couchouron A, Dupont I, Fabra C, et al
    Comparison of hepatitis E virus nucleic acid test screening platforms and RNA prevalence in French blood donors.
    Transfusion. 2017;57:223-224.
    >> Share

    October 2016
  27. MAFIRAKUREVA N, Mapako T, Khoza S, Emmanuel JC, et al
    Cost effectiveness of adding nucleic acid testing to hepatitis B, hepatitis C, and human immunodeficiency virus screening of blood donations in Zimbabwe.
    Transfusion. 2016 Oct 2. doi: 10.1111/trf.13858.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016